Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Majadahonda, Madrid
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Clinical Trials in Majadahonda, Madrid
1 recruiting
Majadahonda, Madrid, Spain
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals
155 enrolled
22 locations
NCT07190300
Feedback